Screener
Vor Biopharma VOR PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other current assets | 2,859 | 1,745 |
| Total current assets | 500,778 | 458,105 |
| Restricted cash | 168 | 168 |
| Property and equipment, net | 565 | 533 |
| Operating lease right-of-use assets | 2,827 | 2,936 |
| Other assets | 2,408 | 2,384 |
| Total assets | $506,746 | $464,126 |
| Liabilities and stockholders’ deficit |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's PP&E (net)?
- Vor Biopharma (VOR) reported PP&E (net) of $565K in Q1 2026.
- How has Vor Biopharma's PP&E (net) changed year-over-year?
- Vor Biopharma's PP&E (net) decreased by 90.6% year-over-year, from $5.99M to $565K.
- What is the long-term trend for Vor Biopharma's PP&E (net)?
- Over 5 years (2020 to 2025), Vor Biopharma's PP&E (net) has grown at a -35.4% compound annual growth rate (CAGR), from $4.73M to $533K.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Vor Biopharma's pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude